The stock market experienced some selling pressure today, but index-level performance didn't reflect that. The S&P 500 (+0.6%) reached a fresh all-time high of 6,100.81, powered by mega caps and ...
For the eighth time in the past nine quarters, trucking and logistics company J.B. Hunt (JBHT) fell short of EPS expectations in Q4 as the company continues to navigate through what it calls a ...
2-yr: -1 bp to 4.23% 3-yr: -1 bp to 4.29% 5-yr: -2 bps to 4.38% 10-yr: -3 bps to 4.58% 30-yr: -3 bps to 4.81% ...
2-yr: -1 bp to 4.35% 3-yr: -2 bps to 4.45% 5-yr: -3 bps to 4.56% 10-yr: -3 bps to 4.76% 30-yr: -3 bps to 4.95% ...
U.S. Treasuries are on track to give back some of their gains from Wednesday ahead of the 8:30 ET release of December Retail Sales (Briefing.com consensus 0.5%; prior 0.7%) and weekly Initial Claims ...
At first glance, Target's (TGT) upwardly revised Q4 comparable sales guidance, which now calls for growth of approximately 1.5% compared to its prior forecast of flat comps, looks quite bullish for ...
U.S. Treasuries have dipped from their best levels of the day, but they remain above levels that were seen in immediate reaction to the December CPI report. The pace of today's action slowed ...
The stock market rallied following pleasing inflation data in the form of the December Consumer Price Index (CPI) report. The S&P 500 (+1.8%) traded above its 50-day moving average (5,957) at its ...
Taiwan Semiconductor Manufacturing rises on upbeat Q4 results, underpinned by robust AI demand (TSM)
Headline earnings and sales were robust in Q4, expanding by 55% yr/yr to $2.24 and 37% to $26.88 bln, respectively. Aside from IoT and DCE (digital consumer electronics), which fell by 15% and 6% ...
Microsoft (MSFT +2%) takes a leap higher today after announcing its new Quantum Ready program, marking another step further into the quantum computing field. The news has had a ripple effect on ...
Eli Lilly struggles to meet sky-high expectations as Q4 Mounjaro and Zepbound sales fall short (LLY)
Sales of Eli Lilly's (LLY) blockbuster diabetes and weight loss drugs, Mounjaro and Zepbound, are very strong, but they're not quite as robust as the company and analysts had anticipated in Q4.
Total industrial production increased 0.9% month-over-month in December (Briefing.com consensus 0.3%) following an upwardly revised 0.2% increase (from -0.1%) in November. The capacity utilization ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback